These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19543877)

  • 21. The use of methylphenidate among students: the future of enhancement?
    Outram SM
    J Med Ethics; 2010 Apr; 36(4):198-202. PubMed ID: 20338928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-carnitine for cognitive enhancement in people without cognitive impairment.
    Chen N; Yang M; Zhou M; Xiao J; Guo J; He L
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD009374. PubMed ID: 28349514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Doping for the brain].
    Iglseder B
    Z Gerontol Geriatr; 2018 Feb; 51(2):143-148. PubMed ID: 29209802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of psychostimulants on sustained attention over a 24-h period.
    Whitehurst LN; Agosta S; Castaños R; Battelli L; Mednick SC
    Cognition; 2019 Dec; 193():104015. PubMed ID: 31284175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
    Lundqvist T
    Pharmacol Biochem Behav; 2005 Jun; 81(2):319-30. PubMed ID: 15925403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expectations regarding cognitive enhancement create substantial challenges.
    Racine E; Forlini C
    J Med Ethics; 2009 Aug; 35(8):469-70. PubMed ID: 19644002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between chronic cannabis use and cognitive functions.
    Ray R; Prabhu GG; Mohan D; Nath LM; Neki JS
    Drug Alcohol Depend; 1978 Sep; 3(5):365-8. PubMed ID: 710267
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study.
    Jager G; de Win MM; van der Tweel I; Schilt T; Kahn RS; van den Brink W; van Ree JM; Ramsey NF
    Neuropsychopharmacology; 2008 Jan; 33(2):247-58. PubMed ID: 17460617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response: addiction, memory, and spirit.
    Eisen V; Wanner J
    Addict Sci Clin Pract; 2010 Dec; 5(2):15-6. PubMed ID: 22002449
    [No Abstract]   [Full Text] [Related]  

  • 30. PASS assisted prediction and pharmacological evaluation of novel nicotinic analogs for nootropic activity in mice.
    Khurana N; Ishar MP; Gajbhiye A; Goel RK
    Eur J Pharmacol; 2011 Jul; 662(1-3):22-30. PubMed ID: 21554868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive processing of drug-related stimuli: the role of memory and attention.
    Weinstein A; Cox WM
    J Psychopharmacol; 2006 Nov; 20(6):850-9. PubMed ID: 16401648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive enhancement as a pharmacotherapy target for stimulant addiction.
    Sofuoglu M
    Addiction; 2010 Jan; 105(1):38-48. PubMed ID: 20078461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Turbocharging the brain.
    Stix G
    Sci Am; 2009 Oct; 301(4):46-9, 52-5. PubMed ID: 19780452
    [No Abstract]   [Full Text] [Related]  

  • 34. Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.
    Forlini C; Hall W; Maxwell B; Outram SM; Reiner PB; Repantis D; Schermer M; Racine E
    EMBO Rep; 2013 Feb; 14(2):123-8. PubMed ID: 23318628
    [No Abstract]   [Full Text] [Related]  

  • 35. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.
    Cakic V
    J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Effects of a Polyphenol-Rich Leaf Extract of
    Wightman EL; Jackson PA; Forster J; Khan J; Wiebe JC; Gericke N; Kennedy DO
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32717999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 38. Glue sniffing: a pilot study of the cognitive effects of long-term use.
    Allison WM; Jerrom DW
    Int J Addict; 1984 Jul; 19(4):453-8. PubMed ID: 6480177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention.
    Callahan PM; Terry AV
    Handb Exp Pharmacol; 2015; 228():161-89. PubMed ID: 25977082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study.
    Kang YK; Lee BY; Bucci LR; Stohs SJ
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29462997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.